Edan Instruments Inc (300206) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.038x

Based on the latest financial reports, Edan Instruments Inc (300206) has a cash flow conversion efficiency ratio of 0.038x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥78.00 Million ≈ $11.41 Million USD) by net assets (CN¥2.04 Billion ≈ $298.88 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Edan Instruments Inc - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Edan Instruments Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Edan Instruments Inc (300206) financial obligations for a breakdown of total debt and financial obligations.

Edan Instruments Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Edan Instruments Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
SHANG.FOS.PHARM.GR.H YC 1
F:08HH
N/A
Wuxi ETEK Microelectronics Co Ltd
SHG:688601
-0.007x
MasterBrand Inc.
NYSE:MBC
0.065x
Shinva Medical Instrument Co Ltd
SHG:600587
-0.003x
Temple Bar Investment Trust
LSE:TMPL
0.014x
Hotai Finance Corp
TW:6592
-0.067x
TripAdvisor Inc
NASDAQ:TRIP
0.189x
ZYNP Corp
SHE:002448
0.008x

Annual Cash Flow Conversion Efficiency for Edan Instruments Inc (2008–2024)

The table below shows the annual cash flow conversion efficiency of Edan Instruments Inc from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Edan Instruments Inc.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥2.01 Billion
≈ $293.80 Million
CN¥371.36 Million
≈ $54.34 Million
0.185x +135.93%
2023-12-31 CN¥1.96 Billion
≈ $287.38 Million
CN¥153.96 Million
≈ $22.53 Million
0.078x -56.70%
2022-12-31 CN¥1.85 Billion
≈ $270.91 Million
CN¥335.16 Million
≈ $49.04 Million
0.181x +32.14%
2021-12-31 CN¥1.73 Billion
≈ $253.43 Million
CN¥237.28 Million
≈ $34.72 Million
0.137x -63.97%
2020-12-31 CN¥1.81 Billion
≈ $265.33 Million
CN¥689.50 Million
≈ $100.90 Million
0.380x +328.33%
2019-12-31 CN¥1.30 Billion
≈ $190.03 Million
CN¥115.29 Million
≈ $16.87 Million
0.089x +35.62%
2018-12-31 CN¥1.26 Billion
≈ $184.06 Million
CN¥82.34 Million
≈ $12.05 Million
0.065x -28.10%
2017-12-31 CN¥1.25 Billion
≈ $183.16 Million
CN¥113.96 Million
≈ $16.68 Million
0.091x +348.65%
2016-12-31 CN¥1.23 Billion
≈ $179.36 Million
CN¥-44.88 Million
≈ $-6.57 Million
-0.037x -256.51%
2015-12-31 CN¥1.22 Billion
≈ $177.96 Million
CN¥28.45 Million
≈ $4.16 Million
0.023x +240.54%
2014-12-31 CN¥1.16 Billion
≈ $170.12 Million
CN¥7.99 Million
≈ $1.17 Million
0.007x -73.10%
2013-12-31 CN¥1.18 Billion
≈ $172.64 Million
CN¥30.13 Million
≈ $4.41 Million
0.026x -62.81%
2012-12-31 CN¥1.18 Billion
≈ $172.14 Million
CN¥80.78 Million
≈ $11.82 Million
0.069x +77.31%
2011-12-31 CN¥1.14 Billion
≈ $166.63 Million
CN¥44.10 Million
≈ $6.45 Million
0.039x -87.14%
2010-12-31 CN¥217.47 Million
≈ $31.82 Million
CN¥65.51 Million
≈ $9.59 Million
0.301x -4.24%
2009-12-31 CN¥152.19 Million
≈ $22.27 Million
CN¥47.88 Million
≈ $7.01 Million
0.315x +7.51%
2008-12-31 CN¥119.27 Million
≈ $17.45 Million
CN¥34.90 Million
≈ $5.11 Million
0.293x --

About Edan Instruments Inc

SHE:300206 China Medical Devices
Market Cap
$1.19 Billion
CN¥8.11 Billion CNY
Market Cap Rank
#8390 Global
#2105 in China
Share Price
CN¥13.99
Change (1 day)
+1.75%
52-Week Range
CN¥11.10 - CN¥15.60
All Time High
CN¥25.00
About

Edan Instruments, Inc. engages in the research, development, manufacture, and service of medical electronic equipment and in vitro diagnostic products in China and internationally. The company offers ECG products, including resting ECG, stress test, holter, wireless solution, and ECG workstation products; patient monitoring systems, such as modular and compact patient monitor, vital signs, and te… Read more